Literature DB >> 19541682

Risk factors for respiratory syncytial virus hospitalisation in children with heart disease.

K Kristensen1, L G Stensballe, J Bjerre, D Roth, N Fisker, T Kongstad, A L Svendsen, B W Nielsen.   

Abstract

OBJECTIVE: To assess the risk and risk factors for respiratory syncytial virus (RSV) hospitalisation and determinants of the severity of RSV disease in children with heart disease.
METHODS: By using a database on RSV tests in Denmark all children with RSV diagnosed with heart disease in Denmark from January 1996 to April 2003 were identified. For each case child one control child matched for age and centre was drawn from the population of children with heart disease. Clinical information was obtained through a review of all records.
RESULTS: Data were obtained on 313 pairs. Median age at admission was 280 days (range 15-2379). In the multivariate analysis predictors of RSV hospitalisation were Down syndrome (odds ratio (OR) 3.24, 95% CI 1.80 to 5.80), cardiomyopathy (OR 5.84, 95% CI 1.26 to 27.16) and haemodynamically significant heart disease (OR 1.53, 95% CI 1.04 to 2.26). During RSV hospitalisation predictors of the need for respiratory support (supplemental oxygen, nasal continuous positive airway pressure or mechanical ventilation) were young age (relative risk (RR) 0.47, 95% CI 0.32 to 0.67 per additional year of age) and cardiac decompensation (RR 1.81, 95% CI 1.02 to 3.23). The incidence rate of RSV hospitalisation among children with any heart disease aged 0-23 months was 5.65 per 100 child-years.
CONCLUSION: In children with heart disease risk factors for RSV admission are Down syndrome, cardiomyopathy and haemodynamically significant heart disease. Young age and cardiac decompensation are associated with a more severe course of RSV disease.

Entities:  

Mesh:

Year:  2009        PMID: 19541682     DOI: 10.1136/adc.2008.143057

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  17 in total

1.  A decade of respiratory syncytial virus epidemiology and prophylaxis: translating evidence into everyday clinical practice.

Authors:  Bosco A Paes; Ian Mitchell; Anna Banerji; Krista L Lanctôt; Joanne M Langley
Journal:  Can Respir J       Date:  2011 Mar-Apr       Impact factor: 2.409

2.  Palivizumab use in infants with Down syndrome-report from the German Synagis™ Registry 2009-2016.

Authors:  Arne Simon; Susanne Gehrmann; Gudrun Wagenpfeil; Stefan Wagenpfeil
Journal:  Eur J Pediatr       Date:  2018-04-12       Impact factor: 3.183

3.  The impact of prophylaxis on paediatric intensive care unit admissions for RSV infection: a retrospective, single-centre study.

Authors:  Michelle L Butt; Amanda Symington; Marianne Janes; Louann Elliott; Susan Steele; Bosco A Paes
Journal:  Eur J Pediatr       Date:  2010-12-22       Impact factor: 3.183

4.  Respiratory syncytial virus prevention in children with congenital heart disease: who and how?

Authors:  Nam Kyun Kim; Jae Young Choi
Journal:  Korean J Pediatr       Date:  2011-05-31

5.  Increased pro-inflammatory cytokine production in Down Syndrome children upon stimulation with live influenza A virus.

Authors:  Chantal J M Broers; Reinoud J B J Gemke; Michel E Weijerman; Koen F van der Sluijs; A Marceline van Furth
Journal:  J Clin Immunol       Date:  2011-12-15       Impact factor: 8.317

6.  Predictors and incidence of hospitalization due to respiratory syncytial virus (RSV)-associated lower respiratory tract infection (LRTI) in non-prophylaxed moderate-to-late preterm infants in Bosnia and Herzegovina.

Authors:  Hajrija Maksić; Suada Heljić; Fahrija Skokić; Darinka Šumanović-Glamuzina; Veroslava Milošević; Almir Zlatanović; Notario Gerard
Journal:  Bosn J Basic Med Sci       Date:  2018-08-01       Impact factor: 3.363

7.  Managing the morbidity associated with respiratory viral infections in children with congenital heart disease.

Authors:  Joseph M Geskey; Stephen E Cyran
Journal:  Int J Pediatr       Date:  2012-02-29

8.  Risk factors for severe respiratory syncytial virus lower respiratory tract infection.

Authors:  Constanze Sommer; Bernhard Resch; Eric A F Simões
Journal:  Open Microbiol J       Date:  2011-12-30

9.  Respiratory syncytial virus-associated hospitalizations over three consecutive seasons in children with congenital heart disease.

Authors:  B Resch; S Kurath-Koller; J Hahn; W Raith; M Köstenberger; A Gamillscheg
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-04-28       Impact factor: 3.267

10.  Increased risk of RSV infection in children with Down's syndrome: clinical implementation of prophylaxis in the European Union.

Authors:  Dianne van Beek; Bosco Paes; Louis Bont
Journal:  Clin Dev Immunol       Date:  2013-06-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.